Physician profile
Craig S Baum
NPI 1063498145
$951.79
in general payments reported to CMS, 2019-2025
17 companies · $151 in 2025
The $151 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.11 · 2021: $15.98 · 2022: $126 · 2023: $114 · 2024: $534 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $255.18 | 2022-2024 | Qelbree |
| Merck Sharp & Dohme LLC | $99.42 | 2021-2024 | Vaxneuvance, Gardasil 9, M-M-R II |
| Seqirus USA INC | $97.96 | 2024-2025 | Flucelvax |
| Sanofi Pasteur INC. | $89.94 | 2020-2025 | |
| Ironshore Pharmaceuticals INC. | $71.79 | 2023-2024 | Jornay Pm |
| Pfizer INC. | $49.79 | 2023-2024 | |
| Cranial Technologies, INC | $48.80 | 2024-2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $35.42 | 2023-2024 | Ycanth |
| Kowa Pharmaceuticals America, INC. | $32.48 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $27.64 | 2022-2024 | Bexsero, Pediarix, Rotarix |
| Novo Nordisk INC | $24.82 | 2024 | Wegovy |
| Collegium Pharmaceutical, INC. | $24.28 | 2025 | Jornay Pm |
| Biomerieux INC | $22.82 | 2023 | |
| Hologic Sales and Service, LLC | $21.57 | 2025 | Aptima |
| Lnhc, INC | $20.50 | 2025 | Zelsuvmi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $15.08 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.